Citius Oncology – Talk Bio

Actionable Insights Powered by AI

Citius Oncology Explores Strategic Alternatives Ahead of LYMPHIR Commercial Launch

Citius Oncology, LYMPHIR, strategic alternatives, commercial launch, cutaneous T-cell lymphoma, immunotherapy